Specifically for the lmwh dalteparin, there is very good quality evidence that at prophylactic doses it can be used without reference to renal function, while at therapeutic doses this paper supports its use, particularly in patients with a crcl between 30 and 60 mlminute. Low molecular weight heparinantixa activityanticoagulation therapyrenal insufficiencydosage adjustment. Low molecular weight heparin lmwh statpearls ncbi bookshelf. Utilization of low molecular weight heparins in special populations. Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of nonstsegment elevation acute coronary syndrome. Heparins, including unfractionated heparin and a variety of low molecular weight lmw heparin products, are used extensively as anticoagulants. However, validation of timing and performing of the test is necessary. Enoxaparin is low molecular weight heparin lmwh and was first approved for. In haemodialysis patients, there are very few data on the pharmacokinetics of lmwh after the end of the session. Lmwh dosing, anticoagulation therapy uc san diego health. Adult drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in. The use of lmwh needs to be monitored closely in patients at extremes of weight or in patients with renal dysfunction. Appropriate dosing of lmwh in patients with severe renal insufficiency is uncertain clearance of the anti. In most patients with endstage renal disease esrd, prophylactic dosage of enoxaparin does not appear to be associated with an increased bleeding risk and can be used without the need for monitoring and adjustment of regimens.
Find dosing information about xarelto for initial deep vein thrombosis dvt and pulmonary embolism pe treatment. Low molecular weight heparin dosing recommendations clinical scenario lmwh dosing recommendations enoxaparin preferred lmwh dalteparin no dosecapping vte prophylaxis orthopedic surgery hipknee replacement, hip fracture 30mg q12h 5000 units daily trauma 30mg q12h 5000 units daily acute spinal cord injury 30mg q12h 5000 units. This book is distributed under the terms of the creative commons. However individualised dosing based on xa levels is even better, although at this time are not justified in most renal failure or obese patients. Discontinue lmwh and commence rivaroxaban 02 hours before the time that the next scheduled dose of lmwh would be due. However, the results of this study suggest that lmwh monotherapy is as safe as vka. Heparin sodium injection heparin sodium dose, indications. In the case of significant renal failure, defined as a crcl dose should be adjusted based on antifactor xa.
Low molecular weight heparin prescribing and administration adults. Renal function should be assessed in all elderly patients 12. Low molecular weight heparins in patients with renal insufficiency. The renal drug handbook the st georges hospital, adult critical. Low molecular weight heparin an overview sciencedirect. Enoxaparin 20 mg for thromboprophylaxis in severe renal. Provided that hemostasis has been established, the initial dose should be given 12 to 24 hours after surgery. Utilization of low molecular weight heparins in special. Patients with significant renal failure may need a reduction in dosage and should be monitored accordingly. Guideline for anticoagulation and prophylaxis using low. As a result, patients with renal insufficiency require dosage adjustment. Enoxaparin dose adjustment table for 1mgkg twice daily.
Lowmolecularweight heparin is cleared almost exclusively by the kidney, and the drug can accumulate in patients with renal insufficiency. The information contained in this book has been compiled. Tinzaparin largest licensed lmwh and the clearance is less dependent on renal. Dalteparin the multicentre openlabel comparison of lowmolecular weight heparin versus oral anticoagulant. For renally excreted drugs with a narrow therapeutic index, the total daily maintenance dose may be reduced either by decreasing the dose or by increasing the dosing interval, or sometimes by a combination of both. The authors agree that an assessment of renal function should be performed in all patients receiving therapeutic doses of lmwhs and that a reduction in enoxaparin dosage is required in patients with severe and moderate renal insufficiency. The food and drug administration fda approved enoxaparin lovenox, sanofi aventis u. For hip replacement surgery, a dose of 40 mg subcutaneously once a day given initially 12 hours prior to surgery may be considered. Introduction this guidance is produced as a consensus statement by the nephrologists. The peak lmwh anti coagulant response occurs approximately 34 hours after subcutaneous injection, and there is no drug accumulation with repeated dosing over peri ods of up to 2 weeks. Renal dosage adjustment guidelines for antimicrobials the pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients. Because lowmolecularweight heparin binds less avidly to heparinbinding proteins in plasma than heparin, lmwh produces a more predictable dose response, and resistance is rare. Increasing the prophylactic doses of lmwh may be appropriate in morbidly obese patients body mass index or 40 kgm2.
June 2011 this clinical pearl focuses on the utilization of dalteparin and enoxaparin in patients with renal impairment and obesity. The authors explore efficacy and safety outcomes in multiple degrees of renal impairment when using fdaapproved dosing regimens for enoxaparin and find that a more multitiered dosing strategy appears to be needed. For patients weighing less than 50kg, call primary service to adjust to nearest syringe size. Drug dosing during continuous renal replacement therapies. Xa effect of lmwh correlates with crcl but this varies amongst different lmwhs in patients with acute dvt and severe renal failure, we suggest ufh over lmwh grade 2c. The pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients. Considerations for use from the atrial fibrillation toolkit. Low molecular weight heparin lmwh tinzaparin unfractionated heparin ufh heparin heparin induced thrombocytopenia hit act activated clotting times 5. Usual dose is 40 mg subcutaneously per day, the usual duration of administration is 7 to 10 days. Also, correlation of antixa activity with bleeding tendency remains debatable, especially in patients with renal insufficiency who have other reasons for bleeding. Aim the aim of this policy is to provide guidance for using low molecular weight heparin lmwh in patients with renal impairment for prophylaxis and treatment of dvt pe acs.
The fifth edition of 2007 has been significantly expanded by dosage tables for children. Guide for the use of thromboprophylaxis in obese and low. Adult drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous. Dosing guidelines book school of medicine university of. Prophylaxis and treatment of vte in renal impairment 1. In this context, we need to stress that the choice of dalteparin is based on hospital choice of anticoagulation for all non renal patients and is not evidencebased in ckd. Dose adjustment requiredprecaution advised for crcl dose adjustment requiredprecaution advised for obese patients with a bmi. Use of low molecular weight heparins in patients with renal.
Administration of lmwh with followup of antixa activity is a reasonable alternative. Pediatric drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in psychiatry. The continuous nature of the fluid and solute removal has less impact on hemodynamic variables in critically ill patients, making crrt preferred over intermittent hemodialysis for some patients in the intensive care arena. Anticoagulation dosing at ucdmc indication agent standard. If between 8 24 hours since last dose of lmwh, then dose of protamine should be halved i. Pdf lowmolecularweight heparins in renal impairment and. Prophylaxis and treatment of vte in renal impairment. Discontinue lmwh once inr in therapeutic range for 2 consecutive days.
Usual dose is 30 mg subcutaneously every 12 hours, the usual duration of administration is 7 to 10 days. Munar, pharmd, bcps, and harleen singh, pharmd oregon state university college of pharmacy, portland, oregon. With a higher risk of bleeding seen with lmwh patients with renal. Lowmolecularweight heparin in patients with chronic renal.
Manufacturers information 1 for enoxaparin, does not recommend dosage adjustments for extremes of body weight. Biochemistry, pharmacology, and concurrent drug precautions john a. Thus, unfractionated heparin still remains the gold standard in patients with a gfr below 30 mlmin when therapeutic dosing is necessary. Tylenol acetaminophen dosing, indications, interactions. Enoxaparin dose requires adjustment with a creatinine. Qa 238 3 lmwh in renal impairment treatment version. Lowmolecularweight heparin in patients with renal insufficiency. A dose reduction is recommended in patients with severe ri. Available evidence and clinical practice recommendations across medical and surgical settings. Issues of low molecular weight heparin use in hemodialysis patients william e. Renal impairment and obesity angela shogbon, pharmd, bcps and janene marshall, pharmd, last updated. Discontinue lmwh and commence apixaban at the time that the next scheduled dose of. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of lowmolecularweight heparin for the treatment of venous thromboembolism.
Low molecular weight heparinantixa activityanticoagulation therapy renal insufficiencydosage adjustment. Lowmolecularweight heparin use in special populations. Enoxaparin has become the treatment of choice for various thromboembolic diseases. At least 5 days and until a therapeutic oral anticoagulant effect has been achieved inr 2 to 3. Disclosures grants from servier and bayer for expanding the thrombosis clinic at. Many clinical trials have demonstrated greater safety and efficacy of lowmolecularweight heparin lmwh than of ufh. The information on dosage adjustments in renal impairment given in this book is.
Differences are noted in the degree of accumulation of various lmwhs in patients with moderatetosevere renal impairment, and thus, the degree of dose adjustment may differ among the various lmwhs. Discuss the use of low molecular weight heparin in patients with severe renal impairment. The interest of low molecular weight heparins lmwh regarding bleeding risk is controversial in renal failure patients. Enoxaparin dose adjustment is commonly recommended for thromboprophylaxis in patients with severe renal insufficiency crcl of dose reduction varies among different countries and practice guidelines.
The calculator does warn that some patients with egfrs between 40 and 30 will not need the dose of enoxaparin recommended, although most will. Low molecular weight heparins lmwh are a class of anticoagulants used therapeutically for treatment of thrombosis and. Please see the attached document for dosing guidelines for lmwhs at uw medicine. In some patients receiving therapeutic doses of lmwh, activity can be measured by quantifying the presence of antifactor xa afxa for dose adjustment. Heparin and lmwh are anticoagulants to prevent thrombosis. Enoxaparin prescribing, administration and monitoring. Is impaired renal function a contraindication to the use. Lmwh commence warfarin in combination with lmwh, and monitor inr.
Low molecular weight heparins in patients with renal. Lowmolecularweight heparins lmwh have been shown to be safer, more effective and more convenient than unfractionated heparin ufh in many clinical situations. Heparin ufh protocol dialysate effluent patient aptt circuit aptt arterial line venous line. Presently, there does not appear to be consensus on a weightbased dosing protocol for thromboprophylaxis in these patients, but it is clear that the standard dose regimen with an lmwh provides. They are used in the prevention of blood clots and treatment of venous thromboembolism deep vein thrombosis and pulmonary embolism and in the treatment of myocardial infarction heparin is a naturally occurring polysaccharide that inhibits coagulation, the process that leads to thrombosis. Standard heparin versus low molecular weight heparin. Health care industry heart attack drug therapy dosage and administration health aspects thromboembolism. Low molecular weight heparin for the treatment of deep vein. Dec 01, 2004 lowmolecularweight heparin use in special populations. Definition nci substances comprised of fragmented heparin molecules derived from unfractionated heparin that bind to antithrombin iii with a molecular weight ranging from to 10,000 daltons, which causes changes in property from unfractionated heparin, including decreased protein binding, enhanced bioavailability, decreased platelet interaction, and decreased binding to thrombin. Enoxaparin prescribing, administration and monitoring enoxaparin is the low molecular weight heparin lmwh used at wuth. Guidelines for administration of anticoagulation for. Use of enoxaparin in endstage renal disease kidney.
Empirical dose adjustment and biological monitoring seem to be. Because lmwh has more predictable pharmacokinetics and anticoagulant effect, lmwh is recommended over ufh for patients with massive pulmonary embolism and for initial treatment of deep vein thrombosis. Includes dosages for prevention of thromboembolism in atrial fibrillation, deep vein thrombosis, deep vein thrombosis prophylaxis and more. Pediatric drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents. Low molecular weight heparins lmwhs are now the mainstay option in the prevention and treatment of venous thromboembolism. However, because lmwh is primarily eliminated through the kidneys, patients with renal insufficiency are at risk of lmwh accumulation and bleeding. Heparin lmwh thrombin medical specialties clinical medicine. Use of enoxaparin in endstage renal disease sciencedirect.
Limited data on dalteparin and tinzaparin suggest that there is. Heparin and low molecular weight heparin both heparin and lmwh are classified as indirect thrombin inhibitors because they inhibit the function of thrombin in the coagulation cascade by binding to antithrombin at. Jun 18, 2008 lowmolecularweight heparin lmwh has largely replaced unfractionated heparin for the treatment of venous thromboembolism. Dosing guidelines for varying degrees of renal impairment are stated accordingly. If warfarin is not tolerated or there is a contraindication to its use, low molecular weight heparin lmwh serves as an alternative option hughes, szeki. Empirically reduced dosages of tinzaparin in patients with. Enoxaparin dose adjustment table for 1mgkg twice daily treatment dosing lab titled lmw heparin assay in sunrise draw first level 4 hours after the 2nd or 3rd dose to monitor the peak anticoagulation effect at steady state lmw heparin assay unitsml hold next dose dosage change next level. Lmwh clearance is almost solely via renal excretion. Although a number of new oral agents exist, warfarin is the only agent that is not contraindicated in endstage renal disease, making it the treatment of choice in this patient population. Low molecular weight heparin prescribing and administration for adults clinical guideline, v1a principle author. The predictable anticoagulant effect of lmwh is seen across almost all patient populations, with few exceptions.
Low molecular weight heparin lmwh in hemodialysis patients. General dosing guidelines anticoagulation services. Aug 02, 2014 a useful guide for initiating lowmolecular weight heparin for treatment of venous te is given in table 4. Laboratory monitoring of the anticoagulation effect of lmwhs is generally not necessary, but should be considered in patients with morbid obesity weight 190 kg, those with severe renal impairment, and those with moderate renal impairment with prolonged 10 days lmwh use. Consequently, significant drug accumulation occurs with renal insufficiency. In patients with a bmi 27, use the q12 hour dosing not q24 hours. The antifactor xa range for low molecular weight heparin. Detailed heparin dosage information for adults and children. The anticoagulant activity and pharmacology of standard heparin sh is changed dramatically by the relatively minor molecular modifications that produce lowmolecular. Bennetts drug prescribing in renal failure has been the best pocket book for drug prescribing in patients with renal insufficiency and dialysis since the first edition in 1987. Learn about the dosing amounts available for two common lowmolecularweight heparin lmwh medications enoxaparin and dalteparin from the anticoagulation clinic at uc san diego health.
For patients on dialysis with venous thromboembolism, low. Low molecular weight heparin dosing recommendations clinical scenario lmwh dosing recommendations enoxaparin preferred lmwh dalteparin no dosecapping vte prophylaxis orthopedic surgery hipknee replacement, hip fracture 30mg q12h 5000 units daily trauma 30mg q12h 5000 units daily acute spinal cord injury 30mg q12h 5000 units daily. Qa 238 3 lmwh in renal impairment treatment version 3 final. If enoxaparin was given within the past 8 hours, the dose of protamine should. Guide for the use of thromboprophylaxis in obese and low body weight patients there is limited good evidencebased data to guide dosing of thromboprophylaxis in patients who are obese or of low body weight. Continuous renal replacement therapies crrt are used to manage fluid overload andor renal failure. Empirical dose adjustment and biological monitoring seem to be necessary along with therapeutic doses. Pharmacokinetics of the low molecular weight heparin. In contrast to the dose dependent clearance of unfractionated heparin, the clearance of lowmolecularweight heparin is considered to be primarily via renal excretion. Anticoagulants in renal impairment bc renal agency. Patients with renal diseases are prone to both thrombosis and bleeding, as they have profound changes in all three classic components of coagulation, defined approximately 150 years ago by virchow.
Lowmolecularweight heparin lmwh is a class of anticoagulant medications. Lowmolecularweight heparins in renal impairment and. Patients on dialysis with vte typically do not receive lmwh because their renal clearance may lead to less predictability in the degree of anticoagulation for a given dose, the authors explained. Lovenox enoxaparin dosing, indications, interactions. Enoxaparin for vte prophylaxis in obese sicu patients. Low molecular weight heparin manufacturers recommendations in renal impairment ri. Few dosing recommendations are available for obese patients.
232 413 1433 229 73 558 1322 1519 159 51 1190 597 909 1278 756 34 1511 1097 1421 1203 116 448 937 364 166 1189 87 29 483 468 1094 884 372 600 689